12/19/2024
8:28 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2024
3:10 PM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2024
7:15 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2024
3:01 PM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/29/2024
8:16 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2024
7:40 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/08/2024
7:59 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
09/27/2024
6:15 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/10/2024
3:00 PM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K/A | |
09/10/2024
7:15 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/04/2024
7:10 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024
7:40 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024
6:28 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
07/31/2024
6:15 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form NT 20-F | |
07/05/2024
6:15 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/18/2024
6:30 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/10/2024
6:01 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
6:45 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024
3:30 PM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/20/2024
3:16 PM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/08/2024
7:32 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 424B3 | |
04/29/2024
7:15 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024
7:03 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024
7:15 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024
7:20 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/03/2024
7:10 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/05/2024
7:06 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/23/2024
7:15 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:17 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/16/2024
7:25 PM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/16/2024
3:14 PM | YS Biopharma Co., Ltd. (Subject)
YS Biopharma Co., Ltd. (Subject)
Lakeshore Biopharma (Subject)
Zhang /MD Yi (Filed by)
| Form SC 13G/A | |
02/14/2024
10:23 AM | Wong Fung Ching (Filed by)
YS Biopharma Co., Ltd. (Subject)
YS Biopharma Co., Ltd. (Subject)
Lakeshore Biopharma (Subject)
| Form SC 13D | |
02/14/2024
6:59 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
7:01 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
7:05 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/09/2024
6:10 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/25/2024
11:15 PM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form EFFECT | |
01/26/2024
5:03 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/23/2024
3:18 PM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form POS AM | |
01/22/2024
4:10 PM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024
6:10 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad) Would you like to know the historic win rate of every trade you take before you place it?
Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << |
